Artivion EMEA

Have you heard about the first NEOS interim results that have been published in EJCTS? The objective of this multicenter study was to evaluate the safety and clinical performance of the E-vita Open Neo in the acute and chronic treatment of aneurysms or dissections in the ascending and descending thoracic aorta and the aortic arch. Please read the full article here: bit.ly/3yOXUx7 #ArtivionEMEA #cardiology #cardiovascular #FET

Discover what it's like to be part of the Artivion family with our new colleague Susanne. From groundbreaking research to a supportive and inclusive culture, we are proud to foster an environment where everyone can thrive. Follow us to learn more about our team and career opportunities! (Note: The AMDS stent is not produced at our Hechingen site)🌟🔗 Entdeckt mit unserer neuen Kollegin Susanne, wie es ist, Teil der Artivion-Familie zu sein. Von bahnbrechender Forschung bis hin zu einer unterstützenden und integrativen Kultur sind wir stolz darauf, ein Umfeld zu fördern, in dem jeder gedeihen kann. Folgt uns, um mehr über unser Team und Karrieremöglichkeiten zu erfahren! (Hinweis: der AMDS Stent wird nicht an unserem Standort in Hechingen produziert)🌟🔗 #ArtivionEMEA #ArtivionHechingen #EmployerBranding #CareersAtArtivion #InnovateWithUs

Thank you for an amazing and successful Cadaver Lab in Leuven, Belgium! Big thanks to everyone for the collaboration! Learn more about us and our aortic arch solutions: https://lnkd.in/dPhnfMaB #ArtivionEMEA #cardiology #cardiovascular #FET #Aorticsurgery

"𝐓𝐡𝐢𝐬 𝐦𝐮𝐥𝐭𝐢𝐜𝐞𝐧𝐭𝐞𝐫 𝐬𝐭𝐮𝐝𝐲 𝐢𝐬 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐭𝐨 𝐫𝐞𝐩𝐨𝐫𝐭 𝐭𝐡𝐞 𝐦𝐢𝐝-𝐭𝐞𝐫𝐦 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐨𝐟 𝐄𝐃𝐄-𝐢𝐁𝐄𝐕𝐀𝐑𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐟 𝐜𝐨𝐦𝐩𝐥𝐞𝐱 𝐭𝐡𝐨𝐫𝐚𝐜𝐨𝐚𝐛𝐝𝐨𝐦𝐢𝐧𝐚𝐥 𝐚𝐧𝐞𝐮𝐫𝐲𝐬𝐦𝐬” said Said Abisi (London, UK). Curios? Read the full article: https://lnkd.in/eNXRWA-X #ArtivionEMEA #TAAA #iBEVAR #Endovascular

We are pleased to share that the first NEOS interim results have been published in EJCTS. The objective of this multicenter study was to evaluate the safety and clinical performance of the E-vita Open Neo in the acute and chronic treatment of aneurysms or dissections in the ascending and descending thoracic aorta and the aortic arch. Please read the full article here: bit.ly/3yOXUx7 #ArtivionEMEA #cardiology #cardiovascular #FET

“𝐓𝐡𝐞 𝐄-𝐧𝐬𝐢𝐝𝐞 𝐜𝐚𝐫𝐫𝐢𝐞𝐬 𝐬𝐨𝐦𝐞 𝐭𝐞𝐜𝐡𝐧𝐢𝐜𝐚𝐥 𝐜𝐡𝐚𝐫𝐚𝐜𝐭𝐞𝐫𝐢𝐬𝐭𝐢𝐜𝐬 𝐭𝐡𝐚𝐭 𝐦𝐢𝐠𝐡𝐭 𝐛𝐞 𝐚𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞𝐨𝐮𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐮𝐫𝐠𝐞𝐧𝐭 𝐬𝐞𝐭𝐭𝐢𝐧𝐠” said Dr. M.Piazza (Italy). Curios? Read the full article: https://lnkd.in/eacTux-N #ArtivionEMEA #TAAA #Endovascular

Hear Prof. Tze Tec Chong (SN) talking about initial success in using #iBEVAR technologies. We would like to hear from you: are you familiar with iBEVAR technology? Let us know in the comments field. Learn more https://bit.ly/4c5P2RZ #ArtivionAPAC #TAAA #endovascular

We would like to wish you all a great weekend congratulating the University Hospital of Southampton (UK) for implanting the 𝐟𝐢𝐫𝐬𝐭 𝐍𝐄𝐗𝐔𝐒 𝐃𝐔𝐎™️ 𝐀𝐨𝐫𝐭𝐢𝐜 𝐀𝐫𝐜𝐡 𝐒𝐭𝐞𝐧𝐭 𝐆𝐫𝐚𝐟𝐭 𝐒𝐲𝐬𝐭𝐞𝐦 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐊. This new achievement marks another milestone in advancing aortic technologies with purpose together. Thank you for your collaboration: Ahmed Elbasty , Mohammed Hadi, Ian Nordon, John Rawlins, Amit Modi and a big thank you to Said Abisi for sharing his expertise. Learn more: https://lnkd.in/dPhnfMaB #ArtivionEMEA #vascularsurgery #nexusaorta

An acute type A aortic dissection, specifically a DeBakey Type I, is a challenging and life-threatening operation. The PERSEVERE data has demonstrated the ability of AMDS to reduce major adverse events through 30-days post-op. Hear from Dr. Michael Moon, MD about his key takeaways from the PERSEVERE data and his experience in the DARTS trial. Learn more about the PERSEVERE US IDE Study 30-Day Results: https://bit.ly/440G7hU #AMDS #cardiothoracicsurgery #PERSEVERE #AorticSurgery #ArtivionEMEA

When to choose off-the-shelf versus customized? Hear how Andrew Holden (NZ) makes his decision. Let us know what would influence your choice by writing in the comments field. Learn more: https://bit.ly/4c5P2RZ #ArtivionAPAC #TAAA #endovascular